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Andrographolide, a bioactive phytochemical from Andrographis paniculata, is emerging 
as a promising anticancer agent against various cancers. This study aims to investigate 
anticancer activities of andrographolide against cholangiocarcinoma (CCA) and to 
understand the underlying mechanism. The anti-proliferative activity of andrographolide 
was evaluated in a range of cholangiocarcinoma (CCA) cell lines including HuCCA-1, 
KKU-100, KKU-M213, and RMCCA-1. The anti-migration activity and the corresponding 
mechanism were studied in highly metastatic KKU-M213 cells. The results indicated that 
andrographolide significantly inhibited the proliferation of CCA cells with the 50% inhibitory 
growth concentration (IC50) of ~120 µM. Andrographolide also inhibited CCA cell migration 
and invasion. Our further explorations demonstrated that andrographolide decreased the 
expression of claudin-1, a major tight junction protein, while it up-regulated the expression 
of Snail, a transcriptional repressor of claudin-1. Moreover, andrographolide induced the 
phosphorylation of Jun N-terminus kinase (JNK) and p-38 Mitogen-activated protein kinase 
(MAPK). Treatment with the p-38-specific inhibitor recovered the claudin-1 expression and 
migration ability of CCA cells. This work demonstrated the potential anticancer effects 
of andrographolide, indicating that andrographolide could inhibit CCA cell migration via 
suppression of claudin-1 through the activation of p-38 MAPK signaling pathway. This 
compound would be useful for development of alternative therapeutic agent for CCA.
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INTRODUCTION
Cholangiocarcinoma (CCA) is a cancer that arises in the epithelium of biliary tree, both intra-hepatic 
and extra-hepatic bile ducts (Gores, 2003). The worldwide incidence of this cancer is relatively rare 
than are other gastrointestinal cancers (Shaib and El-Serag, 2004). However, high prevalence has 
been recorded in the Southeast Asian region, in particular the north-eastern part of Thailand (Sripa 
and Pairojkul, 2008). The mortality rate of CCA patients is high due to late clinical presentation. The 
primary treatment strategy for CCA is surgical resection of the tumor. However, only some cases are 
applicable for surgery, posing a limitation of the therapeutic options. The 5-year survival rate after 
resection is very low (20–30%) (Rosen et al., 2010). Most conventional chemotherapeutic agents 
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such as gemcitabine, cisplatin, paclitaxel, and oxaliplatin have 
very limited efficiency in CCA patients and also could induce 
chemo-resistance (Lee et al., 2008; Valle et al., 2010; Weigt and 
Malfertheiner, 2010; Yang et al., 2013). Thus, it is urgently needed 
to find alternative treatments for CCA.
Poor clinical outcomes for CCA are largely due to metastatic 
disease. Metastatic processes in tumor cells involve a series of 
independent steps including cell protrusion, adhesion formation, 
detachment, and cell contraction (Lauffenburger and Horwitz, 1996; 
Friedl and Brocker, 2000). These steps are regulated by complicated 
molecular mechanisms. Intracellular signaling pathways 
including the p-38 MAPK and Jun N-terminus kinase (JNK) are 
ubiquitously activated in most cancer types and play a vital role in 
cancer progression and metastasis. However, the understanding 
of p-38 MAPK and JNK in cancer whether they are either tumor 
suppressor or oncoproteins is still unclear (Wagner and Nebreda, 
2009). Certain proteins involved in epithelial–mesenchymal 
transition (EMT) have also been widely reported to be responsible 
for cancer metastasis (Thiery, 2002). The typical events occurring 
in cell migration include a loss of adherent E-cadherin and an 
increase in vimentin expression (Lamouille et al., 2014). Moreover, 
claudin-1, a major tight junction protein, has been associated with 
metastasis. The high expression of claudin-1 has been found in the 
aggressive cancer tissue, and the knockdown of claudin-1 reduced 
cell migration (Blanchard et al., 2013). Repression of claudin-1 has 
been strongly correlated with the enhanced expression of negative 
transcription factors for EMT proteins (Peinado et al., 2007).
In recent years, active compounds from natural products 
have gained attention for potential use in interventions against 
cancer progression and metastasis. Andrographolide, a 
diterpenoid lactone derived from Andrographis paniculata Nees, 
a herbal medicine widely used across Southeast Asian countries 
(Sareer et al., 2014) has been shown to exhibit a broad range of 
pharmacological properties (Gupta et al., 2017; Islam, 2017; Yang 
et al., 2017), and many recent studies have revealed its promising 
anticancer effects (Lim et al., 2012; Mishra et al., 2015). It has been 
shown to suppress cancer cell proliferation by disrupting proteins 
related to cell cycle regulation and to inhibit MCF-7 breast cancer 
cell proliferation by inducing G1 cell cycle arrest through increased 
p27 and decreased CDK4 (Rajagopal et al., 2003). In addition, this 
compound has been shown to promote apoptosis (Cheung et al., 
2005). It has been demonstrated that andrographolide also inhibits 
cancer cell migration and invasion by interfering expression 
of proteins or cellular signaling pathways that play a key role in 
cancer metastasis. Its migratory inhibition on human non-small 
cell lung cancer A459 cells was mediated through down-regulation 
of PI3K/Akt signaling pathway that contributes to reduced 
expression of MMP-7, an extracellular matrix degradation enzyme 
(Lee et al., 2010). For CCA, crude ethanolic extract from first true 
leaf stage A. paniculata has previously been reported to inhibit cell 
proliferation and to induce apoptosis in HuCCA-1 and RMCCA-1 
cells (Suriyo et al., 2014). However, the effects of purified form of 
andrographolide on other relevant cancer properties including 
migration and invasion remain elusive. In this study, we therefore 
examined the anticancer activities of andrographolide in a range of 
CCA cells focusing on migration and invasion ability of CCA cells 
and elucidated the underlying molecular mechanisms.
MATERIALS AND METHODS
Chemicals and Antibodies
Andrographolide (98% purity), ribonuclease A, and 
phenylmethylsulfonyl fluoride (PMSF) protease inhibitor were 
purchased from Sigma Chemicals (Sigma-Aldrich, St. Louis, MO, 
USA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) was purchased from United States Biological 
(Massachusetts, MA, USA). Propidium iodide (PI), Ham’s 
F-12 nutrient, and 10,000  U/ml penicillin/streptomycin were 
obtained from Invitrogen (Life Technologies, Grand Island, 
NY, USA). Fetal bovine serum (FBS) was purchased from 
Thermo Scientific Hyclone (South Logan, UT). BD Matrigel™ 
matrix growth factor reduced (GFR) was purchased from BD 
Bioscience (San Jose, CA, USA). The TMB sure blue substrate 
was obtained from KPL (Gaithersburg, MD, USA). Bradford 
solution was purchased from Bio-Rad (Hercules, CA, USA). 
Antibodies against actin, Akt, phospho-Akt (Ser473), Erk1/2, 
phospho-Erk1/2, p-38, phospho-p-38, JNK, phospho-JNK, 
and antibodies against EMT proteins as well as horseradish 
peroxidase (HRP)-conjugated anti-rabbit and anti-mouse 
secondary antibodies were from Cell Signaling Technologies 
(Beverly, MA, USA). For immunofluorescence, claudin-1 
antibody was purchased from Santa Cruz Biotechnology (Santa 
Cruz, CA, USA), and anti-mouse antibody conjugated with 
Alexa Fluor 594 was from Thermo Fisher Scientific (Waltham, 
MA, USA). The p-38 MAPK SB 203580 inhibitor and JNK 
inhibitor SP600125 were purchased from Abcam Chemicals 
(Cambridge, UK).
Andrographolide Stock Solution 
Preparation
Andrographolide was dissolved in DMSO at a concentration of 
100 mM as a stock solution and stored at −20°C. Andrographolide 
solution at the desired concentrations was freshly prepared by 
diluting from a stock solution in serum-free Ham’s F-12 media. 
Control experiments received only media and the same amount 
of DMSO. The final concentration of DMSO was adjusted to 1% 
for all andrographolide concentrations.
Cell Culture
The CCA cell lines, HuCCA-1 (Sirisinha et al., 1991) and 
RMCCA-1 (Rattanasinganchan et al., 2006), were kindly gifted 
from Prof. Stitaya Sirisinha and Assoc. Prof. Rutaiwan Tohtong, 
Faculty of Science, Mahidol University, respectively. KKU-
100 (Sripa et al., 2005) and KKU-M213 (Uthaisar et al., 2016) 
CCA cell lines were purchased from the Japanese Collection of 
Research Bioresources Cell Bank. These cells were cultured in 
Ham’s F-12 medium supplement with 10% FBS and 100  U/ml 
of penicillin/streptomycin. All cell lines were maintained in a 
moisture incubator at 37°C with 5% CO2.
Cell Viability by MTT Assay
Cells were seeded at a density of 2 × 104 cells in 100 µl of medium 
and were exposed to different concentrations of andrographolide 
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ranging from 0 to 200  µM for 48  h. After incubation, 10  µl of 
MTT solution (5 mg/ml) was added, and the cells were further 
incubated for 3 h. The production of formazan was solubilized 
by adding 100  µl of DMSO. The absorbance was measured by 
spectrophotometry at 570  nm (JASCO model FP-6200, MD, 
USA). The percentage of cell viability was calculated relative to 
the untreated control cells.
Cell Cycle Analysis
CCA cells were seeded into 24-well plates at a density of 
1.5 × 105 cells per well in 1 ml of medium and then treated with 
0, 25, 50, and 100  µM of andrographolide for 48  h. Cells were 
washed with PBS and trypsinized prior to fixation with chilled 
70% ethanol for 1 h. Following the incubation of ribonuclease A 
(100 µg/ml) at 37°C for 30 min, cells were stained with 25 µg/ml 
of propidium iodide and further incubated for 30 min at 37°C 
in the dark. Cell cycle was analyzed using FACSCanto flow 
cytometer (BD Bioscience) with FACSDiva program from a 
minimum of 30,000 cells.
Wound Healing Assay
CCA cells were seeded onto 24-well plates at a density of 
1.5  ×  105  cells in 1  ml of medium and cultured at 37°C with 
5% CO2 for 48  h. Following the confluence, medium was 
removed, and the cells were treated with various concentrations 
of andrographolide (0, 12.5, 25, and 50  µM), which were then 
incubated for 24  h at 37°C with 5% CO2. After incubation, 
medium with 0.1% FBS was replaced, and the cell monolayer 
was scratched to create a wound gap using a sterile 200-µl 
micropipette tip, and the cells were further incubated for 12 h. 
Images were captured by a phase contrast inverted microscope 
(Olympus model IX83, Shinjuku, Tokyo, Japan) at 0 and 12  h. 
Cell migration index was obtained from measurement of the 
wound length by Image J software (version 1.47V, NIH image, 
National Institutes of Health, Bethesda, MD, USA), relative to the 
untreated control condition.
Matrigel Invasion Assay
CCA cells were cultured in 6-well plates at a density of 
5 × 105 cells in 4 ml of medium and then maintained at 37°C 
with 5% CO2 for 48 h before being treated with 0, 12.5, 25, and 
50 µM of andrographolide for 24 h. Following the incubation, 
both treated and untreated cells were washed with ice-cold PBS 
and harvested. The pre-treated and control cells were suspended 
in serum-free medium at a concentration of 1  ×  105 cells in 
200  µl and were added to the insert of Matrigel-coated PET 
membrane (24-well insert, 8-µM pore size; Millipore, Bradford, 
MA). The inserts were placed into the 24-well plate containing 
medium supplemented with 10% FBS and incubated at 37°C 
with 5% CO2 for 24 h. Cells that did not invade through the pore 
were removed by scraping with sterile cotton swab. The invading 
cells were fixed in 30% methanol for 20 min and stained with 
0.1% crystal violet for 20  min prior to counting under a light 
microscope. Cell invasion index was determined relative to the 
cells in the control condition.
Western Blot Analysis
Cells were grown on 10-cm Petri dish at 2 × 106 cells in 10 ml of 
medium and then cultured for 48 h in 37°C with 5% CO2. After 
incubation, cells were treated with different concentrations of 
andrographolide for 24  h. Following the treatment, they were 
washed with ice-cold PBS and collected. Harvested cells were 
lysed with ice-cold lysis buffer containing 150  mM of NaCl, 
1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, and 
50 mM of Tris, pH 8.0. Cell lysate was centrifuged at 12,000 × g 
for 5 min at 4°C to yield whole-cell extract in supernatants. The 
protein concentration was quantitated using the Bradford assay. 
Protein samples of 50 µg per lane were loaded onto 10% SDS–
PAGE and transferred onto nitrocellulose membranes (Bio-
Rad, Hercules, CA, USA). The membranes were blocked for 
30  min at room temperature using skim milk powder (Merck 
Millipore, Billerica, MA, USA) (2% w/v). After being blocked, 
the membranes were probed with the primary antibodies against 
protein of interest overnight at 4°C at a dilution recommended 
by the manufacturers. After being washed, membranes were then 
incubated with horseradish peroxidase (HRP)-conjugated anti-
rabbit or anti-mouse secondary antibodies at a dilution of 1:500 
for 1.5  h at room temperature. The immunoreactivities were 
detected by 3,3′,5,5′-tetramethylbenzidine (TMB) as a substrate 
of HRP. The intensity of protein bands was evaluated using Image 
J software. All experiments were performed in three independent 
experiments. The intensities of protein bands were normalized 
with the internal control.
Immunofluorescence
KKU-M213 cells were cultured at 1.5 × 105 cells/ml in 24-well 
plates and treated with 50 µM of andrographolide for 24 h. The 
treatment with 1% DMSO served as a control. After incubation, 
cells were fixed with 4% paraformaldehyde for 20 min at room 
temperature and permeabilized with 0.1% Triton X-100 for 
20  min. After being washed, cells were blocked with PBS 
containing 2% bovine serum albumin for 1  h and were then 
incubated with claudin-1 or Snail antibody (1:100) at 4°C 
overnight. After being washed, the KKU-M213 cells were 
subjected to the secondary antibody conjugated with Alexa Fluor 
594 (1:200) for 1 h at room temperature; then 5 µg/ml of Hoechst 
33342 was used to stain nucleus for 20 min. Images were obtained 
from an inverted microscope.
Real-Time Reverse Transcription (RT)-PCR
Total RNA was extracted by RNeasy Mini Kit (Qiagen, Hilden, 
Germany) according to the manufacturer’s protocol. Two 
micrograms of each RNA sample was reverse transcribed using 
RevertAid Reverse Transcription (Thermo Fisher Scientific, 
Waltham, MA, USA). Synthesized cDNA was used in MX 3000p 
qPCR System (Agilent Technologies, Santa Clara, CA, USA) 
experiment using SYBR Green Master Mix (PCR Biosystems, 
London, UK) and analyzed with Software according to the 
manufacturer’s instruction. The real-time PCR conditions were 
40 cycles of 95°C for 2 min, followed by 59°C for 30 s and 72°C 
for 30 s. Actin gene was used as an internal standard to normalize 
the amount of total RNA expression in each reaction.
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Treatment With p-38 and JNK-Specific 
Inhibitors
To verify the role of p-38 and JNK pathways in cell migration 
that mediates through Snail and claudin-1, the antagonists of 
p-38 and JNK were used to perform the experiment. KKU-M213 
cells were pre-treated with 50 µM of andrographolide or DMSO 
(control) for 24  h before being incubated with p-38 MAPK 
inhibitor SB 203580 (5 µM) and JNK inhibitor SP600125 (10 µM) 
for 30 min. The control cells were pre-treated with 1% DMSO. 
Then, the cells were replaced with serum-free Ham’s F-12 and 
further incubated for 3 h. After incubation, they were subjected 
to wound healing assay and Western immunoblotting.
Small Interfering RNA Targeting of 
Claudin-1
Synthetic small interfering RNAs (siRNA) were purchased from 
Santa Cruz Biotechnology (Santa Cruz, CA, USA). The target DNA 
sequence of claudin-1 was GAGGATTACTCCTATGCCGG, and 
siRNA for claudin-1 was 5′-GGAUUUACUCCUAUGCCGGtt-3′ 
and 5′-CCGGCAUAGGAGUAAAUCCtc-3′. KKU-M213 cell 
lines were transfected with siRNA using RNAimax Lipofectamine 
Reagent (Invitrogen) according to manufacturer’s instruction. 
For each experiment, 9 µl of Lipofectamine was mixed with 300 µl 
of Opti-MEM medium and 4 µl of 10 pmol/µl claudin-1 siRNA, 
and then the mixture was pre-incubated at room temperature 
for 20  min. The cells were washed twice with 2  ml of serum-
free Ham’s F-12 and incubated with the pre-incubated mixture 
containing 1.7 ml of serum-free Ham’s F-12 for 24 h at 37°C with 
5% CO2. After incubation, the medium with siRNA was removed 
and replaced with 10% FBS Ham’s F-12 medium, and then the 
cells were further incubated for 24 h. Then migration assay and 
detection of claudin-1 expression using real-time RT-PCR and 
Western blot analysis were performed.
Statistical Analysis
Data were representatives of at least three independent 
experiments. Statistical analysis was performed using two-tailed 
unpaired Student’s t-test and one-way ANOVA and expressed as 
mean ± standard error of mean (SE) of triplicate measurements. 
The GraphPad Prism version 6.0 software was used for statistical 
analysis. Significant value cutoffs were set at p < 0.05.
RESULTS
Andrographolide Attenuates Migration 
and Invasion of CCA Cells
First, we determined the effect of andrographolide on cell viability 
in  four CCA cell lines including HuCCA-1, KKU-100, KKU-
M213, and RMCCA-1. The results indicated that andrographolide 
significantly reduced CCA cell viability in a concentration-
dependent manner. The 50% inhibitory growth concentration 
(IC50) values of andrographolide for CCA cells were 121, 137, 
134, and 134  µM for HuCCA-1, KKU-100, KKU-M213, and 
RMCCA-1, respectively (Figure 1A). Our results indicate that 
andrographolide reduced the CCA cell viability and could induce 
cell apoptosis. With negligible cytotoxic effect, andrographolide 
concentration at maximum of 50 µM was used in all subsequent 
experiments.
The anti-migratory effect of andrographolide was investigated 
in CCA cells by wound healing assay. Cells were treated with sub-
toxic doses of andrographolide (0, 12.5, 25, and 50 µM) for 24 h. 
Figure 1B shows representative photographs of the CCA cell 
migration. Quantitative analysis revealed that migration indices 
substantially decreased at 25 and 50  µM in HuCCA-1, KKU-
M213, and RMCCA-1, but not in KKU-100 cells (Figure 1C), 
suggesting that andrographolide inhibited CCA cell migration 
in a dose-dependent manner. Consistent with previous 
observations, KKU-100 did not seem to exhibit migration 
activity. Furthermore, CCA cell invasion was determined using 
a Matrigel-coated transwell. Figure 1D illustrates the effect of 
andrographolide on CCA cell invasion. The quantitative data 
also showed that andrographolide inhibited the ability of CCA 
cell invasion in a dose-dependent manner (Figure 1E). Our data 
demonstrated that andrographolide suppressed the ability of 
migration and invasion in CAA cells.
Andrographolide Inhibits Claudin-1 
Expression in CCA Cells
To investigate the mechanism through which andrographolide 
inhibits CCA cell migration and invasion, we analyzed the 
expression of EMT proteins including vimentin, E-cadherin, 
claudin-1, and Snail. In this experiment, we used two cell lines, 
migratory KKU-M213 and non-migratory KKU-100 cells. 
The results showed that claudin-1 expression was substantially 
decreased in KKU-M213 cells upon exposure to andrographolide 
treatment, whereas the expression of Snail, a repressor of 
claudin-1, was up-regulated than was control. No apparent 
changes of claudin-1 and Snail were observed in KKU-100 cells 
(Figure 2). There were no significant changes in the expression 
of other EMT-related proteins following the exposure to 
andrographolide in both cell types. The effect of andrographolide 
on claudin-1 and Snail expression in KKU-M213 cells was 
confirmed by immunofluorescence (Figure 3). From these data, 
andrographolide altered the expression of claudin-1 and Snail 
in migratory KKU-M213 cells but not in non-migratory KKU-
100 cells, suggesting that andrographolide attenuated motility of 
CCA cells through claudin-1 and Snail expression.
Suppression of Claudin-1 Expression 
Inhibits Cell Migration of CCA Cells
Transient suppression of claudin-1 in KKU-M213 cells was 
performed using siRNA specific to claudin-1. Cells treated 
with scramble RNA were used as controls. The real-time 
RT-PCR and Western blot analysis showed that claudin-1, 
compared with the controls, was successfully knocked down by 
its specific siRNA >8-folds (Figures 4A, B). Migration activity 
of KKU-M213 cells was evaluated by wound healing assay. The 
results revealed that the cells treated with si-claudin-1 exhibited 
significant reduction in migration activity than did the control 
Andrographolide Inhibits CCA Migration via Claudin-1Pearngam et al.
5 July 2019 | Volume 10 | Article 827Frontiers in Pharmacology | www.frontiersin.org
FIGURE 1 | Andrographolide inhibits cholangiocarcinoma (CCA) cell migration and invasion. (A) Effect of andrographolide on CCA cell viability. CCA cells were 
treated with various concentrations of andrographolide (0–200 µM) for 48 h, and cell viability was determined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay. The results represented the average of percentage cell viability compared with that of the control. (B) CCA cell monolayer treated with 
andrographolide at the concentrations of 0, 12.5, 25, and 50 µM was scratched, and the size of the wound was photographed at 0 and 12 h following the wound 
scratch. (C) Migration index as indicated by quantitative assessment of wound length. The results represented the average value of migration index compared 
with that of the control. (D) Invasive ability of CCA cells with andrographolide treatment (0, 12.5, 25, and 50 µM) was observed using Matrigel invasion assay. After 
24-h incubation, the invasive cells were photographed. (E) The number of invasive cells were counted and calculated to invasion index. The results showed the 
average invasion index compared with that of the control. Data were presented as mean ± SE, which were derived from three independent experiments, *p < 0.05, 
**p < 0.01.
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FIGURE 2 | Effects of andrographolide on the expression of epithelial–mesenchymal transition (EMT) proteins in CCA cells. (A) KKU-M213 and KKU-100 cells 
were treated with 0, 25, and 50 µM of andrographolide for 24 h prior to harvesting proteins. The expression of EMT-related proteins was evaluated using Western 
immunoblotting with actin as internal control. Representative results of three independent experiments are shown. The level of protein expression was quantified by 
intensitrometric analysis relative to actin as ratios to the untreated control. (B) The graphs present the expression of claudin-1 and Snail in KKU-M213 and KKU-100 
upon the treatment of andrographolide. The results of bar graph are represented by the average of relative intensity compared with that of the control. Data were 
presented as mean ± SE, which were derived from three independent experiments, *p < 0.05, **p < 0.01.
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cells treated with scramble RNA. Similar observations were 
found in the condition of andrographolide treatment, which 
were consistent with the previous experiments (Figures 4C, D). 
The data demonstrated that claudin-1 plays an important role 
in CCA cell migration.
Role of the p-38 MAPK Pathway in the 
Andrographolide-Mediated Inhibition of 
Cell Migration and Claudin-1 Expression
To elaborate further on the potential mechanism by which 
andrographolide inhibits CCA cell migration, the signaling 
pathways including MAPK and Akt pathways were determined 
under andrographolide treatment. The results showed that 
andrographolide enhanced phosphorylation of p-38 MAPK 
and JNK in KKU-M213 cells, but no alteration was observed 
in KKU-100 cells. However, andrographolide did not affect the 
expression of Akt and Erk1/2 in both KKU-M213 and KKU-
100 cells (Figure 5). At 50 µM of andrographolide, significant 
induction of phosphorylation of p-38 MAPK and JNK was 
observed, suggesting that andrographolide increased the 
activation of p-38 MAPK and JNK. It is possible that they further 
regulate the downstream target proteins involving in migratory 
inhibition of CCA.
FIGURE 3 | Immunofluorescence of claudin-1 and Snail in KKU-M213 cells following andrographolide treatment. KKU-M213 cells were treated with 50 µM of 
andrographolide prior to fixing and staining with (A) claudin-1 and (B) snail antibodies. The control cells were treated with 1% DMSO. Anti-mouse secondary 
antibody conjugated with Alexa Fluor 594 was added (red). Hoechst 33342 was used as nuclei counterstain (blue). The images were obtained from Olympus 
IX83 inverted microscope.
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To verify the relationship among the andrographolide-mediated 
inhibition of claudin-1 and p-38 MAPK and JNK activation, the 
KKU-M213 cells were treated with the specific inhibitors of p-38 
MAPK (SB 203580) and JNK (SP600125). The results revealed 
that andrographolide treatment followed by p-38 MAPK inhibitor 
could recover the expression of claudin-1 but suppressed Snail 
expression than did the cells exposed to andrographolide only 
(Figure 6A). Moreover, p-38 MAPK inhibitor reversed the effect 
of andrographolide on CCA cell migration (Figure 6B). However, 
this notion could not be observed with the JNK inhibitor. Taken 
together, these results indicate that claudin-1 and Snail might be 
key proteins downstream of p-38 MAPK, which play a role in 
regulating the migration of CCA cells.
DISCUSSION
Because of high mortality rate and lack of effective curative options 
in CCA, the need for novel therapeutic measures are urgently 
needed. In recent years, a number of studies have indicated that 
the naturally extracted compounds from herbal plants exhibit 
anticancer properties. Andrographolide, a major constituent 
from A. paniculata, has been shown to have multi-functions 
of anticancer activities in variety of cancer types (Lim et al., 
2012; Mishra et al., 2015). The crude extract of A. paniculata 
displays the ability to arrest cell cycle and induce apoptosis in 
CCA cells (Suriyo et al., 2014). However, the effects of purified 
andrographolide on other relevant CCA properties including cell 
migration and invasion have never been described. This current 
study hence explored such effect together with underlying 
molecular mechanism using four different CCA cell lines.
Andrographolide has been shown to inhibit growth in 
several cancer cell types such as breast cancer, colon cancer, 
lung cancer, melanoma, leukemia, prostate cancer, and ovarian 
cancer (Rajagopal et al., 2003). We first provided evidence 
that andrographolide significantly suppressed all CCA cell 
proliferation. The pro-apoptotic effect of andrographolide has 
been associated with various mechanisms depending on the cell 
types. While andrographolide enhanced the expression of Bax, 
caspase-3, and caspase-9, it down-regulated that of Bcl-2, leading 
to apoptosis in melanoma B16F-10 cells (Pratheeshkumar et al., 
2012), and it promoted apoptosis in pancreatic cancer cells via 
inhibition of STAT3 and Akt activation (Bao et al., 2013). In 
addition, the analogue form of andrographolide has previously 
been shown to induce apoptosis by mediating topoisomerase II 
alpha in KKU-M213 cells (Nateewattana et al., 2014).
FIGURE 4 | Inhibitory effect of andrographolide on cell migration mediated by claudin-1. The RNA interference of claudin-1 was used to knock down the claudin-1 
gene in KKU-M213 cells. KKU-M213 were treated with 0 μM (1% DMSO), 50 μM of andrographolide, scramble, and si-claudin-1 prior to harvesting RNA and 
cellular proteins for the detection of claudin-1. (A) The expression of claudin-1 mRNA from real-time RT-PCR; (B) The level of claudin-1 protein from Western blot 
analysis. Actin was used as internal standard. (C) With those treatments, KKU-M213 was scratched to make a wound and photographed at 0 and 12 h to measure 
the wound length for migration index analysis. (D) The results of bar graph are represented by the average of relative intensity compared with that of control. Data 
were derived from three independent experiments and are presented as mean ± SE, *p < 0.05, **p < 0.01. 
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FIGURE 5 | Andrographolide induced phosphorylation of p-38 and JNK in KKU-M213 cells. (A) KKU-M213 and KKU-100 cells were treated with 0, 25, and 50 µM 
of andrographolide for 24 h. Cellular proteins were analyzed for the expression of phospho-Akt (p-Akt) (Ser473), Akt, and MAPK signaling pathways including 
phospho-p-38 (p-p-38) (Thr180/Tyr182), p-38, phospho-Erk1/2 (p-Erk1/2) (Thr202/Tyr204), Erk1/2, phospho-JNK (p-JNK) (Thr183/Tyr185), and JNK. Actin served 
as an internal control. The levels of protein expression in (B) KKU-M213 and (C) KKU-100 cells were quantified by intensitrometric analysis relative to the control. 
The results of the bar graph are represented by the average of relative intensity compared with that of the control. Data were derived from three independent 
experiments and are presented as mean ± SE, *p < 0.05, **p < 0.01.
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We showed that andrographolide effectively inhibited the 
ability of cell migration and invasion in CCA cell lines at 
sub-cytotoxic doses, except for KKU-100 cells, which did not 
migrate and had a low capacity of invasion than had other cell 
lines in our experimental settings. KKU-100 was established 
from poorly differentiated tubular adenocarcinoma with low 
expression of CEA and CA-125 compared with the primary 
tumor (Sripa et al., 2005). KKU-100 cells exhibited high 
expression of thymosin 10 (Tβ10), a protein that inhibits actin 
polymerization, which is commonly found in primary tumors 
but decreases in metastatic tumor cells, causing a low capacity 
in migration (Sribenja et al., 2013). The molecular mechanism 
underlying the andrographolide-mediated inhibition of CCA 
cell migration and invasion was then characterized. We found 
that andrographolide suppressed the level of claudin-1 protein 
in high migratory CCA cells. Claudin-1 is a protein involved 
in the EMT pathway that functions as a major tight junction 
protein. It functions by both promoting and suppressing 
tumors depending on cancer types (Kwon, 2013). However, 
several migratory and invasive cancerous cell types have 
been associated with high expression of claudin-1 including 
breast cancer, colon cancer, liver cancer, oral squamous 
carcinoma, and melanoma (Leotlela et al., 2007; Akasaka et al., 
2010; Yoon et al., 2010; Blanchard et al., 2013). In contrast, 
andrographolide promoted the expression of Snail in a dose-
dependent manner. Snail is an EMT transcriptional repressor 
that has been reported as a negative regulator of epithelial 
proteins including claudin-1 (Martínez-Estrada et al., 2006). 
Interestingly, the expression of claudin-1 and Snail was altered 
only in migratory KKU-M213 cells, but not in less motile KKU-
100 cells, suggesting that andrographolide affects migration-
mediated proteins. Furthermore, the knockdown of claudin-1 
in KKU-M213 cells caused the reduction in cell migration 
than did control. These findings were similar to the effect of 
andrographolide on the reduction of claudin-1 expression and 
the inhibition of cell migration in migratory CCA cells.
FIGURE 6 | Effect of p-38 MAPK inhibitor (SB 203580) and JNK inhibitor (SP500125) on KKU-M213 treated with andrographolide. (A) KKU-M213 was treated with 
50 µM of andrographolide or DMSO control for 24 h prior to the treatment with the inhibitors. Proteins from cell lysate were analyzed for the expression of claudin-1 
and Snail, and actin was used as an internal control. (B) KKU-M213 cells with treatment of andrographolide and the inhibitors were scratched and photographed 
at 0 and 12 h to measure the wound length for migration index analysis. The results of bar graph are represented by the average of relative intensity compared 
with that of the control. Data are presented as mean ± SE, which were derived from three independent experiments. Lowercase letters similar between treatments 
represent no statistically significant difference.
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The intracellular signaling pathways including Akt and MAPK 
have been implicated in cancer cell migration and invasion (Jin 
et al., 2017). Our results revealed that andrographolide caused a 
dose-dependent increase in the cellular level of phosphorylated 
p-38 MAPK and JNK in KKU-M213, but not KKU-100. However, 
there was no noticeable change in total and phosphorylated 
levels of Akt and Erk1/2 at the same dosages. To further elucidate 
the related effects of andrographolide on KKU-M213 cells, we 
explored the effect of andrographolide combined with specific 
inhibitors of the p-38 MAPK and JNK on cell migration. We 
observed that the combined treatment of andrographolide and 
the p-38 MAPK inhibitor recovered the expression of claudin-1 
and migration ability, but this effect was not observed in the 
treatment with the JNK inhibitor. Nevertheless, the activation of 
JNK upon the treatment with andrographolide might play a role 
in other cellular mechanisms.
In the present study, we proposed a schematic presentation of 
possible mechanisms for the inhibitory effect of andrographolide 
on migration of CCA cells (Figure 7). Andrographolide inhibits 
CCA cell migration through the activation of p-38 MAPK, 
leading to promotion of Snail and repression of claudin-1. 
Further investigation including animal studies and the rescue 
experiments are warranted to provide more support to our 
current findings. Taken together, the findings from this study 
highlighted the potential inhibitory effects of andrographolide 
on CCA cells and also revealed its precise molecular mechanism 
of anti-migration property. Andrographolide therefore serves as 
a good promising agent for CCA therapeutic development.
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FIGURE 7 | A working model showing the ability of andrographolide to regulate the migration ability of CCA cells.
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